Submitted by Anonymous (not verified) on 15 October 2025 - 14:45
Human medicines European public assessment report (EPAR): Zutectra, human hepatitis B immunoglobulin, Date of authorisation: 30/11/2009, Revision: 18, Status: Authorised
Source: